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Dimethylarginine dimethylaminohydrolase (DDAH)
metabolizes asymmetric dimethylarginine to generate
L-citrulline and is present in large quantities in the kidney.
We present a new study that optimizes the Prescott–Jones
colorimetric assay to measure DDAH-dependent L-citrulline
generation in kidney homogenates. We found that the
removal of urea with urease is necessary since urea also
produces a positive reaction. Deproteinization with
sulfosalicylic acid was found to be optimal and that protease
inhibitors were not necessary. All assays were conducted in
phosphate buffer, since other common additives can create
false positive and false negative reactions. Arginase or nitric
oxide synthase isoenzymes were not found to influence
L-citrulline production. Our optimized L-citrulline production
assay to measure DDAH activity correlated closely with the
direct measure of the rate of asymmetric dimethylarginine
consumption. Using this assay, we found that both
superoxide and nitric oxide inhibit renal cortical DDAH
activity in vitro.
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Dimethylarginine dimethylaminohydrolase (DDAH) meta-
bolizes the methylarginines asymmetric dimethylarginine
(ADMA) and NW-monomethyl-L-arginine, to generate
L-citrulline, and is highly expressed in the kidney.1 ADMA
is elevated in many systemic diseases, including renal failure,
possibly due to impaired renal DDAH activity.
DDAH activity can be measured by rate of substrate (e.g.
ADMA) consumption, but these assays are time consuming
and costly.2,3 A colorimetric method that detects L-citrulline
production can also be used providing that (1) other
pathways that generate or remove L-citrulline are inactivated
and (2) interfering compounds have been removed.
Here, we have optimized the Prescott–Jones method4 using
diacetyl monoxime derivatization of the ureido group in
L-citrulline to form color5,4 that has been adapted to a 96-well
format.6 Particular attention was paid to nonspecific color
generation by urea.7 Furthermore, we compared this modified
L-citrulline assay to the direct high-pressure liquid chromato-
graphy method measuring rate of ADMA consumption.
RESULTS
Optimization of L-citrulline assay
The enzyme is saturated at between 100 mM and 1 mM
substrate (ADMA) and we therefore use 1 mM ADMA in all
studies. We compared four different homogenization buffers,
and found sodium phosphate buffer, pH¼ 6.5, was without
effect on color formation (Table 1). Without deproteiniza-
tion, both bovine serum albumin and the kidney homogenate
caused turbidity. Sulfosalicylic acid (4%) gave the lowest
blank absorbance and was used for deproteinization. With
deproteinization, there was no background color with bovine
serum albumin although the kidney homogenate still had
high color, suggesting the presence of interfering factors.
Effect of urea on L-citrulline assay
As shown in Figure 1, the high background color seen in the
deproteinized kidney homogenate was reduced by 495% at
t¼ 15 min after incubation with urease. Addition of 1, 5, 10,
50, and 100 mM urea gave color equivalent to B21, 49, 106,
195, and 221 mM L-citrulline, respectively, but gave no
background color at t¼ 0 when preincubated with urease
for 15 min.
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After preincubation with urease, citrulline production in
kidney and other tissue homogenates incubated with 1 mM
ADMA was linear from 0 to 120 min (Figure 2). We used a
45-min incubation in subsequent studies.
Comparison of DDAH activity measured by L-citrulline
accumulation with ADMA consumption
In kidney cortex, the rate of production of L-citrulline¼
0.3976 mM/g protein/min and the corresponding rate
of consumption of ADMA¼ 0.4378 mM/g protein/min are
similar (Figure 3), suggesting that this assay gives a faithful
measurement of DDAH activity. Other tests (Figure S2)
confirmed that there was no citrulline to arginine conversion
and no citrulline generation by activity of arginase or nitric
oxide synthase.
The renal cortex and medulla DDAH activity was
0.3970.01 (n¼ 15) and 0.3070.01 (n¼ 3) mM/g protein/
min, respectively. Inter- and intra-assay coefficient of variation
are 5.6170.28% (n¼ 12) and 4.8270.19% (n¼ 9). The NO
donors and superoxide donor inhibited DDAH activity
(Figure 4).
DISCUSSION
We have used the Prescott–Jones method to measure kidney
DDAH activity from rate of L–citrulline production and
found that urea markedly raises background and must be
removed; deproteinization is essential and the choice of
Table 1 | Effect of buffers and additives on the L-citrulline
assay in the presence of 25 mM L-citrulline
L-citrulline mM Color as % of control
Homogenization buffera
HB1 17.070.8 68
HB2 oMinimal o1
HB3 24.970.6 100
HB4 4100b 464
Buffer base
1% Triton 13.070.9 52
1 M HEPES 27.570.4 110
0.3 M sucrose 4100 500
0.9% normal saline 24.670.6 98
0.1 M sodium phosphate 24.970.6 100
100 mM urea 4100 1419
Additives
0.1 M DTT 4100 384
1% 2-mercaptoethanol oMinimal o1
0.5% Tween 22.271.0 89
1% SDS 22.373.7 89
0.5 M EDTA 25.673.0 102
0.2 M EGTA 33.670.6 134
1 mM ADMA 22.270.8 89
Protease inhibitorsc 23.270.3 95
4% sulfosalicylic acid 28.271.0 113
Protein
1 mg/ml BSA 33.672.8b 134
2 mg/ml BSA 43.377.8b 173
1 mg/ml kidney homogenate 76.3712.1b 305
2 mg/ml kidney homogenate 4100b 415
Protein with deproteinization
1 mg/ml BSA 26.170.8 107
2 mg/ml BSA 25.770.8 103
1 mg/ml kidney homogenate 63.471.1 253
2 mg/ml kidney homogenate 82.671.2 330
ADMA, asymmetric dimethylarginine; BSA, bovine serum albumin; EDTA, ethylene-
diaminetetraacetic acid; EGTA, ethylene glycol-bis(aˆ-aminoethyl ether)-N,N,N’,N’,-
tetraacetic acid; HEPES, hydroxyethylpiperazine-N0-2-ethanesulfonic; SDS, sodium
dodecyl sulfate; DTT, DL-dithiothreitol.
The values reflect effect of an additive on the color generated by a 25 mM L-citrulline
standard (taken as 100%).
aHB1, pH=6.8 contained 20 mM Tris, 1% Triton X-100, 5 mM EDTA, 10 mM EGTA, 2 mM
DTT, 1 mM sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonyl fluoride, 10 mg/
ml leupeptin, and aprotinin; HB2 contained 0.1 M sodium phosphate, pH=6.5
containing 2 mM 2-mercaptoethanol;10 HB3 contained 0.1 M sodium phosphate,
pH=6.5;12 and HB4 was RIPA buffer (Santa Cruz, CA, USA), containing 20 mM Tris,
pH=7.6, 137 mM sodium chloride, 0.2% Nonidet P-40, 0.1% sodium deoxycholate,
0.02% SDS, 0.0008% sodium azide, and protease inhibitors.
bThe supernatant was opalescent.
cProtease inhibitors: 0.1 mg/ml phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin,
and aprotinin.
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Figure 1 | Time course of the urea effect on color formation
without substrate (ADMA) in the absence (solid circle) and
presence of urease (open circle). Each time point determined in
triplicate.
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Figure 2 | Time course of DDAH activity in different rat tissues:
kidney cortex (solid circle), liver (open circle), cerebellum
(inverted solid triangle), and aorta (open triangle). Each time
point determined in triplicate.
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deproteinization method influences background color; the
modified method correlates well with rate of ADMA
consumption; and both superoxide and NO, known to
inhibit DDAH activity, produce declines in rate of L-citrulline
formation in kidney homogenates.
Knipp and Vasak6 adapted the Prescott–Jones assay to a
96-well plate method for measurement of activity of the
purified DDAH enzyme. However, in complex tissues, there
may be agents that reduce or increase color development and
alter L-citrulline metabolism. Of particular note, the devel-
opment of color is not specific for L-citrulline but also occurs
with urea,7 and there is a urea concentration gradient in
kidney (B4 mM in cortex and B20 mM in inner medulla).8
Even in renal cortex, urea accounts for more than 90% of
baseline absorbance, and therefore obscures DDAH-induced
changes in color due to citrulline formation. In the presence
of urease, the effect of urea (up to 100 mM) can be completely
removed from kidney cortex and medulla. Kulhanek et al.9
reported that urease treatment was not required for citrulline
assay in liver and brain. Our results, however, demonstrate
that where urea concentration is measurable, urease should
be used. Although the urea effect can be prevented by initial
ion-exchange chromatography,10 this is more costly and time
consuming compared to urease.
Another difficulty is that the diacetyl monoxime reagent
can detect protein-bound L-citrulline as well as free L-
citrulline. Although no separate protein-removing step was
required in the purified enzyme system,6 in tissues, protein
precipitation is mandatory. We found that 4% sulfosalicylic
acid gave lowest background.
Buffer/additives also influence color development, for
example, 2-mercaptoethanol (in HB2) reduces color forma-
tion,5 which might explain our observation of a higher renal
DDAH activity than a previous study using HB2.10 Without
urease treatment, the high background color due to urea
obscures DDAH-dependent L-citrulline formation until
Bt¼ 45 min (Figure S1), which might also explain the
longer incubation time used previously.11–13
In addition to DDAH, ornithine carbamoyltransferase and
nitric oxide synthase generate L-citrulline. In this assay,
activity of both enzymes can be ignored since ornithine
carbamoyltransferase is not detectable in kidney14 and 1 mM
ADMA used as substrate is a potent nitric oxide synthase
inhibitor. On the other hand, L-citrulline can be converted to
L-arginine by argininosuccinate synthase and lyase. However,
in tissue homogenate, citrulline consumption by arginino-
succinate synthase and lyase requires added aspartate15 and
ATP, and we found no citrulline consumption under the
conditions of our assay (Supplementary Material). Further-
more, arginases, which might indirectly increase L-citrulline
consumption by increasing rate of L-arginine utilization,16 are
not active since arginase inhibition did not affect L-citrulline
formation and there was no l-arginine consumption.
Both oxidative and nitrosative stress have been reported to
inhibit DDAH activity,17,18 and in this study we show that
both superoxide and NO donors have an acute inhibitory
action on renal cortex DDAH activity, measured from
L-citrulline production.
In conclusion, this colorimetric assay of L-citrulline
accumulation is a simple and inexpensive method optimized
for detection of renal tissue DDAH activity in vitro, which
agrees well with the more costly and time-consuming method
of measuring ADMA consumption. This can also be adapted
for other tissues, even with low activity such as cerebellum,
but should be optimized before use.
MATERIALS AND METHODS
Preparation of tissue and reagents
Male Sprague–Dawley rats from Harlan (Indianapolis, IN, USA)
were used. Tissues were collected after perfusion with cold
phosphate-buffered saline and stored at 801C. Protein concentra-
tion was determined by Bradford assay. Tissue homogenate was
adjusted to the concentration of 20 mg/ml.
Control NONOate Nitrite DMNQ
D
D
AH
 a
ct
iv
ity
 (µ
M
 
Ci
t/g
 p
ro
te
in
/m
in
)
0.0
0.1
0.2
0.3
0.4
Control
0.1 mM
1 mM
∗
∗
∗
∗
∗
#
#
#
Figure 4 | The effect of NO and superoxide on the L-citrulline
assay to detect renal DDAH activity. DEA NONOate and nitrite were
used as NO donors; and 2,3-dimethoxy-1,4-naphthoquinone was
used as superoxide donor. All measurements were in triplicate.
*Po0.05 vs control; #Po0.05 0.1 mM vs 1 mM.
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Figure 3 | Correlation of L-citrulline formation as a measure of
DDAH activity (solid circle, solid line) with the rate of ADMA
consumption (open circle, dashed line).
888 Kidney International (2007) 72, 886–889
t e c h n i c a l n o t e s Y-L Tain and C Baylis: Colorimetric assay for kidney tissue DDAH activity
Assay procedures
Several pilot studies were conducted to optimize the assay including
evaluation of homogenization buffer, deproteinization reagents, and
other pathways of citrulline metabolism (Supplementary Material &
Table S1). Recommended assay procedures are summarized in
Table 2. A time-course study was conducted with preincubation
of urease with homogenates of rat kidney cortex, liver, cerebellum,
and aorta, then incubation with 1 mM ADMA from 0 to 120 min.
We also investigated the impact of NO and superoxide (diethyl-
amine NONOate, sodium nitrate, and 2,3-dimethoxy-1,4-naphtho-
quinone) on DDAH activity.
Comparison of L-citrulline assay and ADMA degradation by
High-pressure liquid chromatography
We compared the rate of L-citrulline production by DDAH with the
rate of ADMA degradation at t¼ 0, 30, 45, 90, and 120 min. In this
study, 400ml of 1 mM ADMA was mixed with the 100 ml of kidney
homogenate (20 mg/ml), and 100ml of the mixture was collected for
high-pressure liquid chromatography analysis of ADMA at the
various times, as shown above. ADMA (and L-arginine) levels were
measured in tissue homogenate using reverse-phase high-pressure
liquid chromatography with the Waters AccQ-Fluor fluorescent
reagent kit as published previously.19
Statistical analysis
Data are presented as mean7s.e.m. The effects of arginase inhibitor,
NO, and superoxide were compared by unpaired t-test. The
correlation between L-citrulline formation and ADMA consumption
was analyzed by Pearson’s correlation coefficient.
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Table 2 | Recommend assay procedures/conditions for the
measurement of renal cortical DDAH activity
1. Homogenize tissue with 5 sodium phosphate buffer, pH=6.5
2. Adjust protein concentration to 20 mg/ml
3. Preincubate urease (100 U/ml homogenate) with tissue homogenate
in 371C water bath for 15 min
4. Add 100ml sample to 400ml 1 mM ADMA in sodium phosphate
buffer (respective blank is sample omitting ADMA)
5. Incubate mixture in 371C water bath for 45 min
6. Stop reaction by addition of 0.5 ml of 4% sulfosalicylic acid
7. Vortex and centrifuge at 3000 g for 10 min
8. Add 100ml supernatant into a 96-well plate in triplicate
9. Serially dilute 100mm L-citrulline standard to 0, 3.125, 6.25, 12.5, 25,
50, and 100mm
10. Add 100ml of standard into the 96-well plate in triplicate
11. Mix one part of oxime reagent with two parts of antipyrine/H2SO4
reagent to make the ‘color mixture’
12. Add 100ml of color mixture into the wells
13. Cover the plate with a sealing tape
14. Shake on a plate shaker for 1 min
15. Incubate the plate in 601C water bath for 110 min in the dark
16. Cool the plate in an ice bath for 10 min
17. Measure the absorbance by spectrophotometric analysis at 466 nm
18. Subtract the value of respective blank
19. The DDAH activity is represented as mm L-citrulline formation/g
protein/min at 371C
ADMA, asymmetric dimethylarginine; DDAH, dimethylarginine dimethylamino-
hydrolase.
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